ArticleHeliyon2023

HOXC10 promotes esophageal squamous cell carcinoma progression by targeting FOXA3 and indicates poor survival outcome.

Xiaoting He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.